Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Varaine FFV; Guglielmetti L; Mitnick CD

doi:10.1164/rccm.201705-0988LE

Science Portal

v2.1.5984.produseast1

About MSF Science Portal

About

Frequently Asked Questions (FAQs)

Export All Citations

v2.1.5984.produseast1

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria | Journal Article / Commentary | MSF Science Portal

Science Portal

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Abstract

Countries

Subject Area

Languages

DOI

Published Date

PubMed ID

Journal

Volume | Issue | Pages

Issue Date

Dimensions Badge

Science Portal

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Similar Content

Abstract

Countries

Subject Area

Languages

DOI

Published Date

PubMed ID

Journal

Volume | Issue | Pages

Issue Date

Dimensions Badge